Novotech Investor

Novotech is Australia’s largest independent CRO. The Australian Head Office is in Sydney, with regional offices in Melbourne and Brisbane - providing easy access to the most important population centers in Australia. Supported by regional staff across the country and in New Zealand, our coverage of the Australia/New Zealand region is comprehensive. With Asian services launched in 2007, Novotech’s operations provide access to the most dynamic and fast growing clinical research hubs in the region.

Investor Type: Venture Funds
Technology: Biomarker Discovery & Validation
Founded Date: 1996-03-08
Industry: BioPharma AI
Employee Number: 501-1000
Funding Status: private
Headquarters: Sydney,New South Wales,Australia,Oceania